Key facts
- This page summarizes Christopher J. Neugent's Form 4 filing for Cibus, Inc. (CBUS).
- 6 reported transactions and 6 derivative rows are listed below.
- Accepted by SEC: 01 Jun 2023, 19:11.
Christopher J. Neugent - 01 Mar 2023 Form 4 Insider Report for Cibus, Inc. (CBUS)
- Reporting relationship
- Director
- Issuer ticker
- CBUS
- Reported as of
- 01 Mar 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 01 Jun 2023, 19:11:49 UTC
- Prior SEC filing
- 15 Jun 2022
- Source filing
- View source filing
- Reporting owner signature
- Suzette McNally, Attorney-in-Fact for Christopher J. Neugent
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Christopher J. Neugent filed Form 4 for Cibus, Inc. (CBUS) on 01 Jun 2023.
Change
- Previous filing in this sequence was filed on 15 Jun 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CBUS
transaction
Derivative
Stock Option (Right-to-Buy)
Disposed to Issuer
- Transaction value
- Shares
- -7,500
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 01 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,500
- Exercise price
- $4.55
- Footnotes
- F1
CBUS
transaction
Derivative
Stock Option (Right-to-Buy)
Award
- Transaction value
- Shares
- +7,500
- Change %
- Price
- Shares after
- 7,500
- Date
- 01 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,500
- Exercise price
- $4.55
- Footnotes
- F1
CBUS
transaction
Derivative
Stock Option (Right-to-Buy)
Disposed to Issuer
- Transaction value
- Shares
- -14,408
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 01 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 14,408
- Exercise price
- $4.22
- Footnotes
- F1
CBUS
transaction
Derivative
Stock Option (Right-to-Buy)
Award
- Transaction value
- Shares
- +14,408
- Change %
- Price
- Shares after
- 14,408
- Date
- 01 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 14,408
- Exercise price
- $4.22
- Footnotes
- F1
CBUS
transaction
Derivative
Stock Option (Right-to-Buy)
Disposed to Issuer
- Transaction value
- Shares
- -36,400
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 01 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 36,400
- Exercise price
- $0.3032
- Footnotes
- F1
CBUS
transaction
Derivative
Stock Option (Right-to-Buy)
Award
- Transaction value
- Shares
- +36,400
- Change %
- Price
- Shares after
- 36,400
- Date
- 01 Mar 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 36,400
- Exercise price
- $0.3032
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Christopher J. Neugent is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 1 footnote
Footnote F1
The reported transactions reflect a March 1, 2023 material modification of an outstanding stock option with a 90-day post-separation exercise period to extend the exercise period from 90 days to five years from the date of grant. Calyxt, Inc. effected a one-for-ten reverse stock split of its common stock effective on April 24, 2023 and a one-for-five reverse stock split effective on May 31, 2023. Amounts reported above are pre-split.